QUCY - MAINZ BIOMED N.V.

0.517
-0.008   -1.509%

Share volume: 139,637
Last Updated: 04-22-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.18%

PREVIOUS CLOSE
CHG
CHG%
$0.52
-0.01
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
9.88%
1 Month
7.75%
3 Months
-56.19%
6 Months
-67.89%
1 Year
-83.59%
2 Year
-40.51%
Key data
Stock price
$0.52
P/E Ratio 
0.00
DAY RANGE
$0.49 - $0.53
EPS 
N/A
52 WEEK RANGE
$0.40 - $4.43
52 WEEK CHANGE
-$83.84
MARKET CAP 
6.210 M
YIELD 
N/A
SHARES OUTSTANDING 
17.557 M
DIVIDEND
$0.00
EX-DIVIDEND DATE
12-03-2024
NEXT EARNINGS DATE
04-29-2025
BETA 
0.26
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,604,419
AVERAGE 30 VOLUME 
$719,874
Company detail
CEO: Guido Baechler
Region: US
Website: mainzbiomed.com
Employees: 30
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Mainz Biomed B.V. develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. The company was founded in 2008 and is based in Mainz, Germany.

Recent news